Sale!

Terfamex 30 mg Fentermina

(2 customer reviews)

$95.00$130.00

Clear
SKU: N/A Category:

Description

Terfamex 30 mg Fentermina

Terfamex 30 mg Fentermina is a stimulant similar to an amphetamine. It is an appetite suppressant that affects the central nervous system. It is used together with diet and exercise to treat obesity in people with risk factors such as high blood pressure, high cholesterol, or diabetes.

This medicine is also an Anorexigen , which is that the body refrains from eating more . For example, it makes the desire for some tastes disappear, and even the loss of appetite at normal times of the day.

Dosage and administration

The recommended dose is 15 to 30 mg in the morning, one hour before breakfast. Do not exceed the recommended dose. The duration of treatment can be up to 12 weeks. Oral.

use them only in the short term (usually about 12 weeks) and also then other non-pharmacological strategies for weight loss and healthy dieting and exercise. consequently However, recommendations limiting its use for short-term treatment are controversial.

So one reason for the restriction to 12 weeks is drug tolerance, as it loses its appetite-suppressing effects after the body adjusts. On the contrary, it is  shown that this drug not lose its effect in a trial of 36 weeks. Due to the risk of insomnia, it  recommende taking Terfamex before breakfast or also 1-2 hours later.

available forms

destination

CONTRAINDICATIONS :

it not  administered to patients hypersensitive to the components of the formula, with anorexia , insomnia, asthenia, psychiatric disorders and also who is  treating with antidepressants or monoamine oxidase inhibitors (MAOIs).  Do not administer to children under 12 years old, or elderly.

Additional information

Qts Boxes

3 Boxes 30 mg ( 90 capsules), 4 Boxes 30 mg ( 120 capsules), 5 Boxes 30 mg ( 150 capsules)

2 reviews for Terfamex 30 mg Fentermina

  1. Syndi

    Thank you for your help.

  2. Lilia

    So happy with my pakage

Add a review

Your email address will not be published. Required fields are marked *